The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this study is to assess the well-being of
patients following treatment with insulin detemir (Levemir®) in subjects with type 1 or type
2 diabetes in whom either initiation of or a switch to insulin treatment with a long-acting
basal insulin analogue is needed.